JDM Financial Group’s Idexx Laboratories IDXX Stock Holding History

JDM Financial Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1	Closed	-$505	–	379
2024 Q3	$505	Buy	+1	New	+$486	﹤0.01%	385

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JDM Financial Group's IDXX Position: Q4 2024 in Review

JDM Financial Group sold out of Idexx Laboratories (IDXX) in Q4 2024, closing a stake of 1 share — an estimated $505 sold.

JDM Financial Group first reported a position in IDXX in Q3 2024 and held it in 1 quarter. The position peaked at $505 in Q3 2024. 1,123 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

JDM Financial Group reported no remaining Idexx Laboratories position as of Q4 2024 after selling out during the quarter.
JDM Financial Group sold 1 Idexx Laboratories share in Q4 2024, an estimated $505.
JDM Financial Group first reported a position in Idexx Laboratories in Q3 2024 and held it in 1 quarter.
JDM Financial Group's Idexx Laboratories position peaked at $505 in Q3 2024.
1,123 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on JDM Financial Group's 13F filing for Q4 2024, filed 18 Feb 2025.